A real-world study of clofarabine and cytarabine combination therapy for patients with acute myeloid leukemia

Clofarabine and cytarabine (Clo + Ara-C) combinations have efficacy in treatment of acute myeloid leukemia (AML). We retrospectively analyzed clinical outcomes of 71 AML patients receiving Clo + Ara-C regimens at the University of Minnesota from 2011 to 2016: 44 patients (62%) had newly diagnosed AM...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Leuk Lymphoma
Glavni autori: He, Fiona, Sapkota, Smarika, Parker, Sarah, Defor, Todd, Warlick, Erica, Ustun, Celalettin, Eckfeldt, Craig, Rashidi, Armin, Kurtzweil, Andy, Weisdorf, Daniel, Bejanyan, Nelli
Format: Artigo
Jezik:Inglês
Izdano: 2018
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6839888/
https://ncbi.nlm.nih.gov/pubmed/29415603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2018.1433297
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items